We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Mylan Pharmaceuticals Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published: November 2018
Pages: 16
Code: 1740BF4EA38BEA0F5172856CC5F5C267
Format: PDF
Publisher GlobalData
From Add to basket
$ 250.00

Additonal Information

  • Mylan Pharmaceuticals Pvt Ltd (Mylan), a subsidiary of Mylan NV, is a pharmaceutical company that manufactures generic, speciality and active pharmaceutical ingredients (API). The company provides products such as critical care products, hepato care products, HIV care products, onco care products and women care products, among others. Its products include tablets, capsules, oral solid doses (OSD), injectables, antifungal and antibacterial therapies, injectable antibiotics and antiretrovirals, among others. Mylan owns Active Pharmaceutical Ingredients (API) manufacturing facilities, research and development centers in Telangana, Tamil Nadu, Maharashtra and Andhra Pradesh. The company has operations across Europe, the US, Asia, and Africa. Mylan is headquartered in Bangalore, Karnataka, India.
  • provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
  • GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Reasons to buy

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Add to basket
  • Table of Contents
  • Table of Contents 3
  • List of Tables 4
  • List of Figures 4
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
  • Partnerships 10
  • Mylan Pharma Enters into Distribution Agreement with Gilead Sciences 10
  • Mylan Pharma Enters Into Distribution Agreement With Gilead Sciences 11
  • Licensing Agreements 12
  • Mylan Pharma Enters into Licensing Agreement with Otsuka Novel Products for Delamanid 12
  • Mylan Pharmaceuticals Pvt Ltd - Key Competitors 13
  • Mylan Pharmaceuticals Pvt Ltd - Key Employees 14
  • Mylan Pharmaceuticals Pvt Ltd - Locations And Subsidiaries 15
  • Head Office 15
  • Other Locations & Subsidiaries 15
  • Appendix 16
  • Methodology 16
  • About GlobalData 16
  • Contact Us 16
  • Disclaimer 16
  • List of Tables
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Mylan Pharmaceuticals Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Mylan Pharma Enters into Distribution Agreement with Gilead Sciences 10
  • Mylan Pharma Enters Into Distribution Agreement With Gilead Sciences 11
  • Mylan Pharma Enters into Licensing Agreement with Otsuka Novel Products for Delamanid 12
  • Mylan Pharmaceuticals Pvt Ltd, Key Competitors 13
  • Mylan Pharmaceuticals Pvt Ltd, Key Employees 14
  • Mylan Pharmaceuticals Pvt Ltd, Other Locations 15
  • List of Figures
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Keywords
;